speb/financial-data huggingface dataset:
Financial ratios for KROS — quarterly report dated 2025-06-30
Total revenue: 18168000
Operating income: -39817000
Net income: -30696000
Capital expenditures: 720000
Operating cash flow: -29623000
Depreciation & amortization: 370000
Net tangible assets: 706734000
Owner earnings: -31046000
Return on net tangible assets (%): -4.392883319608226
Buffett classification: The Gruesome
Stock price: 13.35
P/E ratio: 2.2438199987261687
Shares outstanding: 19791837
Book value: 706734000
P/B ratio: 0.3738620526959223
Market cap (USD): 264221023.95
Debt to equity: 0.02540418318631904
Current ratio: 21.114126833203677
Quick ratio: 21.114126833203677
COGS to revenue (%): 0
R&D to revenue (%): 239.44848084544253
SG&A to revenue (%): 79.71158080140907
Free cash flow (dilution-adjusted): -38885000
Buyback yield (%): 0
Retained earnings: -451024000
Receivables turnover: 1.024184001352951
Capitalized R&D asset: 76138030
ROCI (R&D-adjusted, %): -3.387361358825354
FCF margin (%): -214.0301629238221
Revenue growth (%): 58.3591566129863
Rule of 40 score: -155.67100631083582
Financial ratios for KROS — quarterly report dated 2025-09-30
Total revenue: 14262000
Operating income: -15384000
Net income: -7280000
Capital expenditures: 132000
Operating cash flow: 3249000
Depreciation & amortization: 395000
Net tangible assets: 703580000
Owner earnings: -7017000
Return on net tangible assets (%): -0.9973279513346031
Buffett classification: The Gruesome
Stock price: 15.82
P/E ratio: 2.8341874753564156
Shares outstanding: 19791837
Book value: 703580000
P/B ratio: 0.4450195590266921
Market cap (USD): 313106861.34000003
Debt to equity: 0.024771880951704142
Current ratio: 29.856674414743484
Quick ratio: 29.856674414743484
COGS to revenue (%): 0
R&D to revenue (%): 136.86018791193382
SG&A to revenue (%): 71.00687140653484
Free cash flow (dilution-adjusted): -869000
Buyback yield (%): 0
Retained earnings: -458304000
Receivables turnover: 2.562803234501348
Capitalized R&D asset: 64739980
ROCI (R&D-adjusted, %): -4.226111490595721
FCF margin (%): -6.0931145701865095
Revenue growth (%): -21.499339498018493
Rule of 40 score: -27.592454068205
Financial ratios for KROS — annual report dated 2025-12-31
Total revenue: 1882562.11
Operating income: 67569000
Net income: 87014000
Capital expenditures: 1551000
Operating cash flow: 107505000
Depreciation & amortization: 1509000
Net tangible assets: 303132000
Owner earnings: 86972000
Return on net tangible assets (%): 28.691131256350367
Capex to operating income (%): 2.2954313368556587
Buffett classification: The Great
Stock price: 20.36
P/E ratio: 4.630999624428252
Shares outstanding: 19791837
Book value: 303132000
P/B ratio: 1.3293278219389573
Market cap (USD): 402961801.32
Debt to equity: 0.05569520868796432
Current ratio: 15.45184677182326
Quick ratio: 15.45184677182326
Effective tax rate (%): 5.313557569888027
COGS to revenue (%): 0
R&D to revenue (%): 6886.5191385372145
SG&A to revenue (%): 2488.5765920360523
Free cash flow (dilution-adjusted): 77258000
Buyback yield (%): 93.06093003644408
Retained earnings: -481765000
Receivables turnover: 0.29544289234149407
Capitalized R&D asset: 290609570
ROCI (R&D-adjusted, %): 8.390980425497672
FCF margin (%): 4103.875223537777
Revenue growth (%): -46.9700814084507
Rule of 40 score: 4056.905142129326
Financial ratios for KROS — quarterly report dated 2025-12-31
Total revenue: 2969.69
Operating income: -29270000
Net income: -23461000
Capital expenditures: 134000
Operating cash flow: -27292000
Depreciation & amortization: 400000
Net tangible assets: 303132000
Owner earnings: -23195000
Return on net tangible assets (%): -7.651782061940013
Buffett classification: The Gruesome
Stock price: 20.36
P/E ratio: 4.630999624428252
Shares outstanding: 19791837
Book value: 303132000
P/B ratio: 1.3293278219389573
Market cap (USD): 402961801.32
Debt to equity: 0.05569520868796432
Current ratio: 15.45184677182326
Quick ratio: 15.45184677182326
COGS to revenue (%): 0
R&D to revenue (%): 603160.5992544676
SG&A to revenue (%): 395428.4790668386
Free cash flow (dilution-adjusted): -34731000
Buyback yield (%): 0
Retained earnings: -481765000
Receivables turnover: 0.0004660530445699937
Capitalized R&D asset: 45345720
ROCI (R&D-adjusted, %): -10.562257254884328
FCF margin (%): -1169516.010088595
Revenue growth (%): -99.97917760482402
Rule of 40 score: -1169615.9892662
Financial ratios for MED.DE — annual report dated 2021-12-31
Total revenue: 764886363.6363636
Gross profit: 626136363.6363636
Operating income: 12381259.090909092
Net income: 1687823.8636363635
Capital expenditures: 16975394.318181816
Operating cash flow: 93143963.63636364
Depreciation & amortization: 83703036.36363636
Net tangible assets: 143568642.04545453
Owner earnings: 68415465.9090909
Return on net tangible assets (%): 47.653488209096686
Capex to operating income (%): 137.10555762980485
Buffett classification: The Gruesome
Stock price: 4.3522727272727275
P/E ratio: 122.4849103034098
Shares outstanding: 47500000
Book value: 207981242.0454545
P/B ratio: 0.9939980765201549
Market cap (USD): 206732954.54545456
Debt to equity: 2.403841177919165
Current ratio: 1.24613194089769
Quick ratio: 1.2062316860055837
Effective tax rate (%): 39.283089272297225
Interest coverage ratio: 1.16841908847185
COGS to revenue (%): 18.139949487446145
SG&A to revenue (%): 1.2925271133561136
Free cash flow (dilution-adjusted): 73819155.68181819
Buyback yield (%): 0
Retained earnings: 7257489.7727272725
Inventory turnover: 14.339401056958309
Receivables turnover: 8.287983578784555
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6314749397697121
FCF margin (%): 9.650996434407965
Rule of 40 score: 9.650996434407965
Financial ratios for MED.DE — annual report dated 2022-12-31
Total revenue: 749680851.0638298
Gross profit: 608297872.3404256
Operating income: 19544498.936170213
Net income: 10339327.65957447
Capital expenditures: 25209453.191489365
Operating cash flow: 36850528.72340426
Depreciation & amortization: 75961856.38297872
Net tangible assets: 163480917.0212766
Owner earnings: 61091730.85106382
Return on net tangible assets (%): 37.36933457689921
Capex to operating income (%): 128.98490400710784
Buffett classification: The Gruesome
Stock price: 3.734042553191489
P/E ratio: 17.154599130278026
Shares outstanding: 47500000
Book value: 222683829.78723407
P/B ratio: 0.7964970848851628
Market cap (USD): 177367021.27659574
Debt to equity: 2.401415416763009
Current ratio: 1.5336192412754293
Quick ratio: 1.4817033439154992
Effective tax rate (%): 0.5938714932989371
Interest coverage ratio: 1.7294388590793561
COGS to revenue (%): 18.859088974031504
SG&A to revenue (%): 2.6678019015183763
Free cash flow (dilution-adjusted): 9171169.148936171
Buyback yield (%): 0
Retained earnings: -5948044.680851065
Inventory turnover: 14.983979318726151
Receivables turnover: 7.963677584043298
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.4651276591362996
FCF margin (%): 1.2233431247339295
Revenue growth (%): -1.9879439999747117
Rule of 40 score: -0.7646008752407822
Financial ratios for MED.DE — annual report dated 2023-12-31
Total revenue: 811222222.2222222
Gross profit: 660666666.6666666
Operating income: 12995741.11111111
Net income: -11915533.333333334
Capital expenditures: 37721140
Operating cash flow: 86668135.55555555
Depreciation & amortization: 95561381.1111111
Net tangible assets: 192353165.55555555
Owner earnings: 45924707.777777776
Capex to operating income (%): 290.2577057937015
Buffett classification: The Gruesome
Stock price: 2.9666666666666663
Shares outstanding: 47500000
Book value: 217810441.11111104
P/B ratio: 0.6469692910395476
Market cap (USD): 140916666.66666666
Debt to equity: 2.4477166146667284
Current ratio: 2.0502507537999763
Quick ratio: 2.000357353226969
Interest coverage ratio: 0.48838064418474764
COGS to revenue (%): 18.559101492946173
SG&A to revenue (%): 2.4654156964799343
Free cash flow (dilution-adjusted): 44916761.11111111
Buyback yield (%): 0
Retained earnings: -18185871.111111112
Inventory turnover: 18.570893667037446
Receivables turnover: 8.949372257492696
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.59291278441371
FCF margin (%): 5.536924393918642
Revenue growth (%): 8.209009349920375
Rule of 40 score: 13.745933743839018
Financial ratios for MED.DE — quarterly report dated 2024-09-30
Operating income: 25025778.888888888
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.5555555555555554
Shares outstanding: 47500000
Market cap (USD): 121388888.88888888
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MED.DE — quarterly report dated 2024-12-31
Total revenue: 198520412.5
Gross profit: 168034109.375
Operating income: 18854804.166666668
Net income: 10375094.791666668
Capital expenditures: 10622804.166666668
Operating cash flow: 21908335.416666668
Depreciation & amortization: 13698386.458333334
Net tangible assets: 206032715.625
Owner earnings: 13450677.083333332
Return on net tangible assets (%): 6.528418092500853
Capex to operating income (%): 56.340039773240825
Buffett classification: The Good
Stock price: 2.4583333333333335
P/E ratio: 2.813729312312508
Shares outstanding: 47500000
Book value: 232018363.54166675
P/B ratio: 0.5032827210349804
Market cap (USD): 116770833.33333334
Debt to equity: 2.083742298433103
Current ratio: 1.7925765698074148
Quick ratio: 1.746409644543699
Effective tax rate (%): 27.322265890082498
Interest coverage ratio: 3.0661017325260556
COGS to revenue (%): 15.356759912535441
Free cash flow (dilution-adjusted): 6804852.083333334
Buyback yield (%): 0
Retained earnings: 8825117.708333334
Inventory turnover: 3.8186608953929233
Receivables turnover: 1.9140381335897199
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.4463722978383244
FCF margin (%): 3.4277845777362232
Rule of 40 score: 3.4277845777362232
Financial ratios for MED.DE — annual report dated 2024-12-31
Total revenue: 780000000
Gross profit: 648958333.3333334
Operating income: 52500000
Net income: 25951062.5
Capital expenditures: 38612331.25
Operating cash flow: 83922866.66666667
Depreciation & amortization: 52395833.333333336
Net tangible assets: 206032715.625
Owner earnings: 39734564.58333334
Return on net tangible assets (%): 19.28556077261739
Capex to operating income (%): 73.54729761904761
Buffett classification: The Good
Stock price: 2.4583333333333335
P/E ratio: 4.499655200373138
Shares outstanding: 47500000
Book value: 232018363.54166675
P/B ratio: 0.5032827210349804
Market cap (USD): 116770833.33333334
Debt to equity: 2.083742298433103
Current ratio: 1.7925765698074148
Quick ratio: 1.746409644543699
Effective tax rate (%): 22.436263397931537
Interest coverage ratio: 2.100832367290857
COGS to revenue (%): 16.800213675213676
SG&A to revenue (%): 2.5507478632478637
Free cash flow (dilution-adjusted): 37370839.583333336
Buyback yield (%): 0
Retained earnings: 8825117.708333334
Inventory turnover: 16.414049486923954
Receivables turnover: 7.520384052194036
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.81176768006803
FCF margin (%): 4.79113327991453
Revenue growth (%): -3.8487878372825626
Rule of 40 score: 0.9423454426319675
Financial ratios for MED.DE — quarterly report dated 2025-03-31
Total revenue: 192270385.86956522
Gross profit: 158025388.04347825
Operating income: 12067801.086956521
Net income: -105023.91304347826
Capital expenditures: 11115127.173913043
Operating cash flow: 18733516.304347824
Depreciation & amortization: 13977727.173913043
Net tangible assets: 216240343.47826087
Owner earnings: 2757576.0869565215
Capex to operating income (%): 92.10565449182639
Buffett classification: The Gruesome
Stock price: 3.1630434782608696
Shares outstanding: 47500000
Book value: 243270117.39130437
P/B ratio: 0.6176038669629127
Market cap (USD): 150244565.2173913
Debt to equity: 2.0421886150994757
Current ratio: 1.8085570927104273
Quick ratio: 1.7639144119662984
Effective tax rate (%): 1289.340226489414
Interest coverage ratio: 1.987077988462381
COGS to revenue (%): 17.810854059094936
Free cash flow (dilution-adjusted): 7026963.043478261
Buyback yield (%): 0
Retained earnings: 9031855.434782607
Inventory turnover: 4.299334426951198
Receivables turnover: 1.9855276142095275
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.514603148181141
FCF margin (%): 3.6547297763501128
Revenue growth (%): -3.1483042734634563
Rule of 40 score: 0.5064255028866564
Financial ratios for MED.DE — quarterly report dated 2025-06-30
Total revenue: 234065201.1764706
Gross profit: 198195465.88235295
Operating income: 20150309.411764707
Net income: 11726055.294117648
Capital expenditures: 13924328.235294119
Operating cash flow: 21420782.352941178
Depreciation & amortization: 15380871.764705883
Net tangible assets: 244034740
Owner earnings: 13182598.823529415
Return on net tangible assets (%): 5.4019353242613795
Capex to operating income (%): 69.10230483688967
Buffett classification: The Good
Stock price: 3.494117647058824
P/E ratio: 7.545446272306651
Shares outstanding: 47500000
Book value: 273252731.7647059
P/B ratio: 0.6073885781980364
Market cap (USD): 165970588.23529413
Debt to equity: 1.9603481193548973
Current ratio: 1.8243331039821566
Quick ratio: 1.7790848968240476
Effective tax rate (%): 17.10278894641419
Interest coverage ratio: 3.0627683066329845
COGS to revenue (%): 15.32467667719393
Free cash flow (dilution-adjusted): 6442949.4117647065
Buyback yield (%): 0
Retained earnings: 64674147.05882353
Inventory turnover: 4.093612496864935
Receivables turnover: 2.193224324180391
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.321580089272442
FCF margin (%): 2.752630198500598
Revenue growth (%): 21.737520896878358
Rule of 40 score: 24.490151095378955
Financial ratios for MED.DE — quarterly report dated 2025-09-30
Total revenue: 238974318.82352942
Gross profit: 202076522.3529412
Operating income: 31238778.82352941
Net income: 18173215.29411765
Capital expenditures: 13703998.823529413
Operating cash flow: 47286054.11764706
Depreciation & amortization: 15461661.176470589
Net tangible assets: 262778256.47058824
Owner earnings: 19930877.647058822
Return on net tangible assets (%): 7.584675351284101
Capex to operating income (%): 43.86854845045159
Buffett classification: The Good
Stock price: 3.6588235294117646
P/E ratio: 4.326536390706001
Shares outstanding: 47500000
Book value: 291883790.5882354
P/B ratio: 0.5954222990485712
Market cap (USD): 173794117.6470588
Debt to equity: 1.804814020625823
Current ratio: 1.9324566170717716
Quick ratio: 1.8905440336126602
Effective tax rate (%): 28.332091099037505
Interest coverage ratio: 4.859914098017284
COGS to revenue (%): 15.44006764083944
Free cash flow (dilution-adjusted): 32972551.76470588
Buyback yield (%): 0
Retained earnings: 37272336.47058824
Inventory turnover: 4.548442683516657
Receivables turnover: 2.2430111266080592
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.5590239895461986
FCF margin (%): 13.797529344169599
Revenue growth (%): 2.0973291298255163
Rule of 40 score: 15.894858473995114
Financial ratios for MED.DE — quarterly report dated 2025-12-31
Total revenue: 232437805.88235295
Gross profit: 199372535.29411766
Operating income: 4227616.470588235
Net income: 687002.3529411765
Capital expenditures: 16949756.470588237
Operating cash flow: 31532412.94117647
Depreciation & amortization: 24969810.588235296
Net tangible assets: 272845649.41176474
Owner earnings: 8707056.470588237
Return on net tangible assets (%): 3.191202238100557
Capex to operating income (%): 400.92937920240973
Buffett classification: The Gruesome
Stock price: 4.305882352941177
P/E ratio: 6.710007571406712
Shares outstanding: 47500000
Book value: 293685456.4705882
P/B ratio: 0.696423357910435
Market cap (USD): 204529411.76470593
Debt to equity: 1.5656333648166634
Current ratio: 1.6777628252889485
Quick ratio: 1.645554880498397
Effective tax rate (%): 63.76416974655174
Interest coverage ratio: 0.6632792757273837
COGS to revenue (%): 14.225427082619724
Free cash flow (dilution-adjusted): 12995400
Buyback yield (%): 0
Retained earnings: 37715943.52941176
Inventory turnover: 5.153186651998533
Receivables turnover: 2.3007894183230038
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5348106881407195
FCF margin (%): 5.590914933424189
Revenue growth (%): -2.7352365615500975
Rule of 40 score: 2.8556783718740917
Financial ratios for MED.DE — annual report dated 2025-12-31
Total revenue: 922941176.4705882
Gross profit: 778823529.4117647
Operating income: 61764705.88235294
Net income: 30472601.17647059
Capital expenditures: 56608574.11764706
Operating cash flow: 120515525.88235295
Depreciation & amortization: 70941176.47058824
Net tangible assets: 272845649.41176474
Owner earnings: 44805203.52941177
Return on net tangible assets (%): 16.42144693382816
Capex to operating income (%): 91.65197714285715
Buffett classification: The Gruesome
Stock price: 4.305882352941177
P/E ratio: 6.711911811540173
Shares outstanding: 47500000
Book value: 293685456.4705882
P/B ratio: 0.696423357910435
Market cap (USD): 204529411.76470593
Debt to equity: 1.5656333648166634
Current ratio: 1.6777628252889485
Quick ratio: 1.645554880498397
Effective tax rate (%): 26.409451447964607
Interest coverage ratio: 2.379771129477908
COGS to revenue (%): 15.61504142766093
SG&A to revenue (%): 2.4729126832377313
Free cash flow (dilution-adjusted): 60016555.29411765
Buyback yield (%): 0
Retained earnings: 37715943.52941176
Inventory turnover: 22.460579391272457
Receivables turnover: 9.135748311240329
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.813486650352215
FCF margin (%): 6.502749776927981
Revenue growth (%): 18.325791855203615
Rule of 40 score: 24.828541632131596
Financial ratios for MET — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 54.5
Shares outstanding: 643436779
Market cap (USD): 35067304455.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MET — annual report dated 2022-12-31
Total revenue: 67409000000
Net income: 5302000000
Capital expenditures: 0
Operating cash flow: 13044000000
Depreciation & amortization: 673000000
Net tangible assets: 20584000000
Owner earnings: 5975000000
Return on net tangible assets (%): 29.027399922269726
Buffett classification: The Gruesome
Stock price: 64.98
P/E ratio: 7.885801942553754
Shares outstanding: 643436779
Book value: 30125000000
P/B ratio: 1.3879011418894607
Market cap (USD): 41810521899.420006
Debt to equity: 0.5968464730290456
Effective tax rate (%): 16.687617850408547
COGS to revenue (%): 0
SG&A to revenue (%): 8.693201204586924
Free cash flow (dilution-adjusted): 13044000000
Buyback yield (%): 7.9549353820578315
Retained earnings: 40332000000
Receivables turnover: 3.6001388592181156
Capitalized R&D asset: 0
FCF margin (%): 19.350531828094173
Rule of 40 score: 19.350531828094173
Financial ratios for MET — annual report dated 2023-12-31
Total revenue: 67934000000
Net income: 1602000000
Capital expenditures: 0
Operating cash flow: 13721000000
Depreciation & amortization: 718000000
Net tangible assets: 20779000000
Owner earnings: 2320000000
Return on net tangible assets (%): 11.165118629385438
Buffett classification: The Gruesome
Stock price: 61.41
P/E ratio: 24.66507652833333
Shares outstanding: 643436779
Book value: 30253000000
P/B ratio: 1.3061003073543118
Market cap (USD): 39513452598.39
Debt to equity: 0.6223515023303474
Effective tax rate (%): 25.901942645698426
COGS to revenue (%): 0
SG&A to revenue (%): 9.092648747313568
Free cash flow (dilution-adjusted): 13721000000
Buyback yield (%): 7.853021682358463
Retained earnings: 40146000000
Receivables turnover: 2.2498426891869516
Capitalized R&D asset: 0
FCF margin (%): 20.197544675714667
Revenue growth (%): 0.7788277529706715
Rule of 40 score: 20.976372428685337
Financial ratios for MET — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 78.41
Shares outstanding: 643436779
Market cap (USD): 50451877841.39
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MET — annual report dated 2024-12-31
Total revenue: 70131000000
Net income: 4444000000
Capital expenditures: 0
Operating cash flow: 14598000000
Depreciation & amortization: 714000000
Net tangible assets: 18544000000
Owner earnings: 5158000000
Return on net tangible assets (%): 27.81492666091458
Buffett classification: The Gruesome
Stock price: 78.41
P/E ratio: 11.352807795092259
Shares outstanding: 643436779
Book value: 27703000000
P/B ratio: 1.8211701924481103
Market cap (USD): 50451877841.39
Debt to equity: 0.6755586037613255
Effective tax rate (%): 20.95339736748488
COGS to revenue (%): 0
SG&A to revenue (%): 8.54258459169269
Free cash flow (dilution-adjusted): 14598000000
Buyback yield (%): 6.356552297383514
Retained earnings: 42626000000
Receivables turnover: 2.2792005199870005
Capitalized R&D asset: 0
FCF margin (%): 20.81533130855114
Revenue growth (%): 3.234021255924868
Rule of 40 score: 24.04935256447601
Financial ratios for MET — quarterly report dated 2025-03-31
Total revenue: 18288000000
Net income: 950000000
Capital expenditures: 0
Operating cash flow: 4262000000
Net tangible assets: 18457000000
Owner earnings: 950000000
Return on net tangible assets (%): 5.147098661754348
Buffett classification: The Gruesome
Stock price: 77.38
P/E ratio: 13.102404726057893
Shares outstanding: 643436779
Book value: 27755000000
P/B ratio: 1.7938799480821472
Market cap (USD): 49789137959.02
Debt to equity: 0.69281210592686
Effective tax rate (%): 29.83751846381093
COGS to revenue (%): 0
SG&A to revenue (%): 8.546587926509186
Free cash flow (dilution-adjusted): 4262000000
Buyback yield (%): 2.8339514557599963
Retained earnings: 43131000000
Receivables turnover: 0.5665954084952133
Capitalized R&D asset: 0
FCF margin (%): 23.30489938757655
Rule of 40 score: 23.30489938757655
Financial ratios for MET — quarterly report dated 2025-06-30
Total revenue: 17176000000
Net income: 735000000
Capital expenditures: 0
Operating cash flow: 2187000000
Net tangible assets: 18543000000
Owner earnings: 735000000
Return on net tangible assets (%): 3.9637599093997737
Buffett classification: The Gruesome
Stock price: 78.08
P/E ratio: 17.088280171537413
Shares outstanding: 643436779
Book value: 27927000000
P/B ratio: 1.7989595625853119
Market cap (USD): 50239543704.32
Debt to equity: 0.7127869087263222
Effective tax rate (%): 25
COGS to revenue (%): 0
SG&A to revenue (%): 8.995109455053562
Free cash flow (dilution-adjusted): 2187000000
Buyback yield (%): 1.0151366083290005
Retained earnings: 43447000000
Receivables turnover: 0.5249709639953543
Capitalized R&D asset: 0
FCF margin (%): 12.732883092687471
Revenue growth (%): -6.080489938757655
Rule of 40 score: 6.6523931539298164
Financial ratios for MET — quarterly report dated 2025-09-30
Total revenue: 16881000000
Net income: 902000000
Capital expenditures: 0
Operating cash flow: 3567000000
Net tangible assets: 19849000000
Owner earnings: 902000000
Return on net tangible assets (%): 4.544309537004383
Buffett classification: The Gruesome
Stock price: 80.58
P/E ratio: 20.0417996334828
Shares outstanding: 643436779
Book value: 29191000000
P/B ratio: 1.776168533171868
Market cap (USD): 51848135651.82
Debt to equity: 0.6793874824432188
Effective tax rate (%): 25.454545454545453
COGS to revenue (%): 0
SG&A to revenue (%): 9.057520289082401
Free cash flow (dilution-adjusted): 3567000000
Buyback yield (%): 2.8969219068675924
Retained earnings: 43887000000
Receivables turnover: 0.40765515575947836
Capitalized R&D asset: 0
FCF margin (%): 21.13026479473965
Revenue growth (%): -1.717512808570098
Rule of 40 score: 19.41275198616955
Financial ratios for MET — annual report dated 2025-12-31
Total revenue: 75654000000
Net income: 3403000000
Capital expenditures: 0
Operating cash flow: 17092000000
Depreciation & amortization: 753000000
Net tangible assets: 18785000000
Owner earnings: 4156000000
Return on net tangible assets (%): 22.124035134415756
Buffett classification: The Gruesome
Stock price: 77.78
P/E ratio: 14.706586150637673
Shares outstanding: 643436779
Book value: 28921000000
P/B ratio: 1.7304558165561357
Market cap (USD): 50046512670.62
Debt to equity: 0.6978666021230248
Effective tax rate (%): 26.989916326968462
COGS to revenue (%): 0
SG&A to revenue (%): 8.295661828852408
Free cash flow (dilution-adjusted): 17092000000
Buyback yield (%): 7.758782366227747
Retained earnings: 44290000000
Receivables turnover: 1.5012203591626154
Capitalized R&D asset: 0
FCF margin (%): 22.592328231157637
Revenue growth (%): 7.875262009667622
Rule of 40 score: 30.46759024082526
Financial ratios for MET — quarterly report dated 2025-12-31
Total revenue: 23291000000
Net income: 816000000
Capital expenditures: 0
Operating cash flow: 7076000000
Net tangible assets: 18785000000
Owner earnings: 816000000
Return on net tangible assets (%): 4.343891402714932
Buffett classification: The Gruesome
Stock price: 77.78
P/E ratio: 14.706586150637673
Shares outstanding: 643436779
Book value: 28921000000
P/B ratio: 1.7304558165561357
Market cap (USD): 50046512670.62
Debt to equity: 0.6978666021230248
Effective tax rate (%): 26.947179946284688
COGS to revenue (%): 0
SG&A to revenue (%): 7.037052938903439
Free cash flow (dilution-adjusted): 7076000000
Buyback yield (%): 0.9191449622623651
Retained earnings: 44290000000
Receivables turnover: 0.4621688659589245
Capitalized R&D asset: 0
FCF margin (%): 30.380833798462923
Revenue growth (%): 37.971684141934716
Rule of 40 score: 68.35251794039763
Financial ratios for MFF.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.8270676691729324
Shares outstanding: 589186019
Market cap (USD): 1076482726.443609
Buyback yield (%): 0.016902722426320023
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MFF.AX — annual report dated 2022-06-30
Total revenue: -166817241.37931034
Net income: -117778620.68965517
Capital expenditures: 0
Net tangible assets: 982714482.7586207
Owner earnings: -117778620.68965517
Return on net tangible assets (%): -11.985029503079437
Buffett classification: The Gruesome
Stock price: 1.3172413793103448
Shares outstanding: 589186019
Book value: 982714482.7586207
P/B ratio: 0.7897514669360589
Market cap (USD): 776100204.337931
Debt to equity: 0.2816870371721958
Free cash flow (dilution-adjusted): -152848965.5172414
Buyback yield (%): 0
Retained earnings: 166450344.8275862
Receivables turnover: -193.66293034427542
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MFF.AX — annual report dated 2023-06-30
Total revenue: 307732450.33112586
Net income: 214288079.47019866
Capital expenditures: 0
Net tangible assets: 1117393377.4834437
Owner earnings: 214288079.47019866
Return on net tangible assets (%): 19.17749682325943
Buffett classification: The Gruesome
Stock price: 1.5761589403973508
P/E ratio: 4.333655953704705
Shares outstanding: 589186019
Book value: 1117393377.4834437
P/B ratio: 0.831086732852713
Market cap (USD): 928650811.4039735
Debt to equity: 0.21242852333718965
Effective tax rate (%): 29.997879870888468
COGS to revenue (%): 0
SG&A to revenue (%): 0.41319112672055364
Free cash flow (dilution-adjusted): 90761589.4039735
Buyback yield (%): 1.8285446470793985
Retained earnings: 127020529.8013245
Receivables turnover: 1101.1279620853081
Capitalized R&D asset: 0
FCF margin (%): 29.49366870679785
Rule of 40 score: 29.49366870679785
Financial ratios for MFF.AX — annual report dated 2024-06-30
Total revenue: 427656666.6666667
Net income: 298237333.3333333
Capital expenditures: 0
Net tangible assets: 1380693333.3333333
Owner earnings: 298237333.3333333
Return on net tangible assets (%): 21.60054851668727
Buffett classification: The Gruesome
Stock price: 2.2933333333333334
P/E ratio: 4.530619697422187
Shares outstanding: 589186019
Book value: 1380693333.3333335
P/B ratio: 0.9786387058482693
Market cap (USD): 1351199936.9066668
Debt to equity: 0.07879760893077872
Effective tax rate (%): 30
COGS to revenue (%): 0
SG&A to revenue (%): 0.3281448513994871
Free cash flow (dilution-adjusted): 224328666.66666666
Buyback yield (%): 0.8631833835068459
Retained earnings: 87963333.33333333
Receivables turnover: 857.6002673796792
Capitalized R&D asset: 0
FCF margin (%): 52.45531851874946
Revenue growth (%): 38.97028610616142
Rule of 40 score: 91.42560462491087
Financial ratios for MLCNT.PA — annual report dated 2022-12-31
Total revenue: 35334145.74468085
Gross profit: 3835264.8936170214
Operating income: 3671356.3829787234
Net income: 6552127.659574469
Capital expenditures: 0
Depreciation & amortization: 31328.72340425532
Net tangible assets: 20046602.127659574
Owner earnings: 6583456.382978724
Return on net tangible assets (%): 32.84075945167341
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 63.9468085106383
P/E ratio: 21.483298384477997
Shares outstanding: 2201225
Book value: 20053900
P/B ratio: 7.019149071443948
Market cap (USD): 140761313.56382978
Debt to equity: 0.055694530898802205
Current ratio: 2.202938271316427
Quick ratio: 2.202938271316427
Effective tax rate (%): 16.301795609063355
COGS to revenue (%): 89.14572628604054
Buyback yield (%): 0
Retained earnings: 17307805.319148935
Receivables turnover: 7.609186025200458
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.30607603174059
Rule of 40 score: 0
Financial ratios for MLCNT.PA — annual report dated 2023-12-31
Total revenue: 158012222.2222222
Gross profit: 60462222.222222224
Operating income: 10271111.11111111
Net income: 8221111.111111111
Capital expenditures: 795555.5555555555
Operating cash flow: 2210000
Depreciation & amortization: 507777.77777777775
Net tangible assets: 41767777.777777776
Owner earnings: 7933333.333333332
Return on net tangible assets (%): 18.993908116304432
Capex to operating income (%): 7.745564690610125
Buffett classification: The Great
Stock price: 73.83333333333333
P/E ratio: 19.76907707122584
Shares outstanding: 2201225
Book value: 44515555.55555555
P/B ratio: 3.650943521615415
Market cap (USD): 162523779.16666666
Debt to equity: 0.14873702076677317
Current ratio: 1.8699745721943508
Quick ratio: 1.8699745721943508
Effective tax rate (%): 19.304177118551642
Interest coverage ratio: 42.40366972477064
COGS to revenue (%): 61.73573071000135
SG&A to revenue (%): 0.6652087391270717
Free cash flow (dilution-adjusted): 1366666.6666666667
Buyback yield (%): 0
Retained earnings: 21512170
Receivables turnover: 4.6692385986801055
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.02893024807569
FCF margin (%): 0.8649119969622605
Revenue growth (%): 347.1941202823876
Rule of 40 score: 348.0590322793498
Financial ratios for MPX.AX — annual report dated 2021-06-30
Capital expenditures: 154081.95488721805
Buffett classification: The Gruesome
Stock price: 0.22556390977443608
Shares outstanding: 146835132
Market cap (USD): 33120706.466165412
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MPX.AX — annual report dated 2022-06-30
Total revenue: 2571582.0689655175
Gross profit: 444592.4137931035
Operating income: -191258.6206896552
Net income: -1541195.1724137932
Capital expenditures: 3169.655172413793
Depreciation & amortization: 65089.6551724138
Net tangible assets: 12204946.206896553
Owner earnings: -1479275.172413793
Return on net tangible assets (%): -12.12029243994464
Buffett classification: The Gruesome
Stock price: 0.19999999999999998
Shares outstanding: 146835132
Book value: 12204946.206896547
P/B ratio: 2.4061577906345724
Market cap (USD): 29367026.4
Debt to equity: 1.754096699743892
Current ratio: 0.12301696709456855
Quick ratio: 0.12301696709456855
Interest coverage ratio: -0.24082277024556847
COGS to revenue (%): 82.71132704032456
SG&A to revenue (%): 22.194950968060983
Free cash flow (dilution-adjusted): -9291062.068965517
Buyback yield (%): 0.3935659644779534
Retained earnings: -4096362.7586206896
Receivables turnover: 10.566298757420762
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6412558769456507
FCF margin (%): -361.29751335150183
Rule of 40 score: -361.29751335150183
Financial ratios for MPX.AX — annual report dated 2023-06-30
Total revenue: 1492114.5695364238
Gross profit: 336437.74834437086
Operating income: -1370084.1059602648
Net income: -3809254.304635762
Capital expenditures: 0
Depreciation & amortization: 21203.311258278147
Net tangible assets: 8648347.682119206
Owner earnings: -3788050.9933774834
Return on net tangible assets (%): -43.80086384835598
Buffett classification: The Gruesome
Stock price: 0.16556291390728478
Shares outstanding: 146835132
Book value: 8648347.682119206
P/B ratio: 2.810993869747351
Market cap (USD): 24310452.317880798
Debt to equity: 4.4448564036846605
Current ratio: 0.744835411553004
Quick ratio: 0.02787707532386824
Interest coverage ratio: -0.524427859410148
COGS to revenue (%): 77.45228448182121
SG&A to revenue (%): 112.94833369061996
Free cash flow (dilution-adjusted): -16675504.635761589
Buyback yield (%): 0
Retained earnings: -7742847.682119206
Inventory turnover: 0.037641467840197965
Receivables turnover: 3.285982428813945
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.471803469898848
FCF margin (%): -1117.575350862126
Revenue growth (%): -41.97678590375831
Rule of 40 score: -1159.5521367658844
Financial ratios for MPX.AX — annual report dated 2024-06-30
Total revenue: 45840086
Gross profit: 9569515.333333334
Operating income: 9128270
Net income: 5539362.666666667
Capital expenditures: 248966.66666666666
Depreciation & amortization: 108355.33333333333
Net tangible assets: 13838502
Owner earnings: 5398751.333333333
Return on net tangible assets (%): 39.01254148269324
Capex to operating income (%): 2.727424437124084
Buffett classification: The Great
Stock price: 0.16666666666666666
P/E ratio: 4.417930991820478
Shares outstanding: 146835132
Book value: 13838501.999999996
P/B ratio: 1.7684372195776685
Market cap (USD): 24472522
Debt to equity: 1.4717392580979265
Current ratio: 0.6658184431003892
Quick ratio: 0.252434010699607
Effective tax rate (%): 0
Interest coverage ratio: 2.551484725645241
COGS to revenue (%): 79.12413311499168
SG&A to revenue (%): 0.7261984630657107
Free cash flow (dilution-adjusted): 22317289.333333332
Buyback yield (%): 0
Retained earnings: -2443304.6666666665
Inventory turnover: 3.481931998019608
Receivables turnover: 26.330591908757548
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 65.82487955898443
FCF margin (%): 48.68509481708506
Revenue growth (%): 2972.155914558343
Rule of 40 score: 3020.841009375428
Financial ratios for MTB.MC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.5568181818181819
Shares outstanding: 32000000
Market cap (USD): 49818181.81818182
Buyback yield (%): 1.583029197080292
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTB.MC — annual report dated 2022-12-31
Total revenue: 14911702.127659576
Gross profit: 2822340.425531915
Operating income: -1745744.680851064
Net income: 4381914.893617022
Capital expenditures: 26595.744680851065
Operating cash flow: 138297.87234042553
Depreciation & amortization: 111702.12765957447
Net tangible assets: 80684042.5531915
Owner earnings: 4467021.276595745
Return on net tangible assets (%): 5.5364371135108055
Buffett classification: The Gruesome
Stock price: 1.4361702127659577
P/E ratio: 10.487982520029133
Shares outstanding: 32000000
Book value: 80756382.9787234
P/B ratio: 0.5690874840273479
Market cap (USD): 45957446.808510646
Debt to equity: 0.2178340424971348
Current ratio: 10.194557209442188
Quick ratio: 0.988122086904224
Effective tax rate (%): 5.070292694169163
Interest coverage ratio: -3.5908096280087527
COGS to revenue (%): 81.07298280659198
Free cash flow (dilution-adjusted): 111702.12765957447
Buyback yield (%): 0.5462962962962962
Retained earnings: -46942553.19148936
Inventory turnover: 0.18558923438724848
Receivables turnover: 4.282615337610755
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.7534861355986535
FCF margin (%): 0.7490903902404222
Rule of 40 score: 0.7490903902404222
Financial ratios for MTB.MC — annual report dated 2023-12-31
Total revenue: 17900000
Gross profit: 6535555.555555555
Operating income: 1862222.2222222222
Net income: 1202222.2222222222
Capital expenditures: 34444.444444444445
Operating cash flow: 9153333.333333334
Depreciation & amortization: 205555.55555555556
Net tangible assets: 83558888.88888888
Owner earnings: 1373333.3333333333
Return on net tangible assets (%): 1.6435514540643328
Capex to operating income (%): 1.8496420047732696
Buffett classification: The Great
Stock price: 1.6222222222222222
P/E ratio: 43.17929759704251
Shares outstanding: 32000000
Market cap (USD): 51911111.11111111
Current ratio: 10.21993397264581
Quick ratio: 1.3650369438767498
Effective tax rate (%): 35.32576210400478
Interest coverage ratio: 3.741071428571429
COGS to revenue (%): 63.488516449410305
Free cash flow (dilution-adjusted): 9118888.888888888
Buyback yield (%): 0.02996575342465753
Retained earnings: -48678888.88888889
Inventory turnover: 0.1815857685615879
Receivables turnover: 6.7405857740585775
Capitalized R&D asset: 0
FCF margin (%): 50.94351334574798
Revenue growth (%): 20.039951487479478
Rule of 40 score: 70.98346483322746
Financial ratios for MTB.MC — annual report dated 2024-12-31
Total revenue: 9357291.666666668
Gross profit: 4320833.333333334
Operating income: 2423958.3333333335
Net income: 1436458.3333333335
Capital expenditures: 1459375
Operating cash flow: -2940625
Depreciation & amortization: 175000
Net tangible assets: 79710416.66666667
Owner earnings: 152083.3333333335
Return on net tangible assets (%): 0.19079480410862254
Capex to operating income (%): 60.20627417275462
Buffett classification: The Good
Stock price: 1.3750000000000002
P/E ratio: 30.63089195068891
Shares outstanding: 32000000
Book value: 79900000
P/B ratio: 0.5506883604505632
Market cap (USD): 44000000.00000001
Debt to equity: 0.20032853566958697
Current ratio: 11.293342955078478
Quick ratio: 1.3882374165614286
Effective tax rate (%): 26.68793195108985
Interest coverage ratio: 5.171111111111111
COGS to revenue (%): 53.82388956918624
Free cash flow (dilution-adjusted): -2942708.3333333335
Buyback yield (%): 0
Retained earnings: -45791666.66666667
Inventory turnover: 0.08806280052455195
Receivables turnover: 14.799011532125206
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.4019157523146952
FCF margin (%): -31.448291216742735
Revenue growth (%): -47.72462756052141
Rule of 40 score: -79.17291877726414
Financial ratios for MTB.MC — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 79710416.66666667
Buffett classification: The Gruesome
Stock price: 1.3750000000000002
Shares outstanding: 32000000
Book value: 79804166.66666667
P/B ratio: 0.5513496580170208
Market cap (USD): 44000000.00000001
Debt to equity: 0.20056910144624862
Current ratio: 11.293342955078478
Quick ratio: 1.3882374165614286
Buyback yield (%): 0
Retained earnings: -45791666.66666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTB.MC — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 88184705.88235295
Buffett classification: The Gruesome
Stock price: 1.7647058823529411
Shares outstanding: 32000000
Book value: 89410588.23529412
P/B ratio: 0.6315872577270754
Market cap (USD): 56470588.23529412
Debt to equity: 0.2284898485506388
Current ratio: 7.321021318790282
Quick ratio: 0.7149231531978179
Buyback yield (%): 0
Retained earnings: -53483529.4117647
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MULT.DE — annual report dated 2021-12-31
Total revenue: 225567032.96703297
Gross profit: 161476923.07692307
Operating income: 91481318.68131869
Net income: -3850549.4505494502
Capital expenditures: 12683516.483516483
Operating cash flow: -81013186.81318681
Depreciation & amortization: 18941758.241758242
Net tangible assets: 150748351.64835164
Owner earnings: 2407692.30769231
Capex to operating income (%): 13.864597347684027
Buffett classification: The Great
Stock price: 3.5795454545454546
Shares outstanding: 21412140
Book value: 190143956.04395604
P/B ratio: 0.4030931616431317
Market cap (USD): 76645728.4090909
Debt to equity: 0.8293773948020875
Current ratio: 1.3374120995098404
Quick ratio: 1.3374120995098404
Effective tax rate (%): 50.85324232081911
Interest coverage ratio: 429.1134020618557
COGS to revenue (%): 28.4128886420547
SG&A to revenue (%): 14.172342229107596
Free cash flow (dilution-adjusted): -93696703.2967033
Buyback yield (%): 0
Retained earnings: 75489010.98901099
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.515057410857906
FCF margin (%): -41.538296649225884
Rule of 40 score: -41.538296649225884
Financial ratios for MULT.DE — annual report dated 2022-12-31
Total revenue: 230270652.17391303
Gross profit: 195604347.82608694
Operating income: 122805434.78260869
Net income: 12796739.130434781
Capital expenditures: 511956.52173913043
Operating cash flow: -37332608.69565217
Depreciation & amortization: 19045652.173913043
Net tangible assets: 161484782.60869566
Owner earnings: 31330434.782608695
Return on net tangible assets (%): 19.401478130931707
Capex to operating income (%): 0.4168842548747134
Buffett classification: The Great
Stock price: 2.5000000000000004
P/E ratio: 4.183124267391491
Shares outstanding: 21412140
Book value: 195615217.39130437
P/B ratio: 0.27365125634842136
Market cap (USD): 53530350.00000001
Debt to equity: 0.28884344820688346
Current ratio: 0.6169307272100325
Quick ratio: 0.6169307272100325
Effective tax rate (%): 13.370125091979398
Interest coverage ratio: 11.69575569358178
COGS to revenue (%): 15.054590769840784
SG&A to revenue (%): 15.93446275413148
Free cash flow (dilution-adjusted): -49184782.60869565
Buyback yield (%): 0
Retained earnings: 82266304.34782608
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 36.162367529054784
FCF margin (%): -21.359553266713554
Revenue growth (%): 2.085242309131009
Rule of 40 score: -19.274310957582546
Financial ratios for MULT.DE — annual report dated 2023-12-31
Total revenue: 266205952.3809524
Gross profit: 207036904.76190478
Operating income: 130390476.1904762
Net income: 19569047.61904762
Capital expenditures: 307142.85714285716
Operating cash flow: 187828571.42857143
Depreciation & amortization: 17876190.476190478
Net tangible assets: 183545238.0952381
Owner earnings: 37138095.23809524
Return on net tangible assets (%): 20.233755788763638
Capex to operating income (%): 0.235556204806077
Buffett classification: The Great
Stock price: 4.0777777777777775
P/E ratio: 4.46183945005475
Shares outstanding: 21412140
Book value: 218626190.47619057
P/B ratio: 0.3993755207301001
Market cap (USD): 87313948.66666666
Debt to equity: 0.28733541705237237
Current ratio: 1.384591887812011
Quick ratio: 1.384591887812011
Effective tax rate (%): 13.438651922064246
Interest coverage ratio: 257.7129411764706
COGS to revenue (%): 22.226793612178184
SG&A to revenue (%): 15.47181961692746
Free cash flow (dilution-adjusted): 174944047.6190476
Buyback yield (%): 0
Retained earnings: 103878571.42857143
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.655778125284417
FCF margin (%): 65.71755667157096
Revenue growth (%): 15.605679606925788
Rule of 40 score: 81.32323627849675
Financial ratios for MULT.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.166666666666667
Shares outstanding: 21412140
Market cap (USD): 89217250
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MULT.DE — annual report dated 2024-12-31
Total revenue: 274142222.2222222
Gross profit: 194621111.1111111
Operating income: 119275555.55555555
Net income: 22482222.22222222
Capital expenditures: 548888.8888888889
Operating cash flow: -27618888.888888888
Depreciation & amortization: 13861111.11111111
Net tangible assets: 178707777.77777776
Owner earnings: 35794444.44444444
Return on net tangible assets (%): 20.02959518021351
Capex to operating income (%): 0.460185564705444
Buffett classification: The Great
Stock price: 4.21875
P/E ratio: 4.017950927275872
Shares outstanding: 21412140
Book value: 215281111.11111104
P/B ratio: 0.4196023755116051
Market cap (USD): 90332465.625
Debt to equity: 0.4231573188544179
Current ratio: 1.299057818748729
Quick ratio: 1.299057818748729
Effective tax rate (%): 12.949578385819999
Interest coverage ratio: 183.81506849315068
COGS to revenue (%): 29.007246846730002
SG&A to revenue (%): 16.751240232158494
Free cash flow (dilution-adjusted): -41760000
Buyback yield (%): 1.1414623789763416
Retained earnings: 109128888.88888888
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.948821538810336
FCF margin (%): -15.232969099575241
Revenue growth (%): 2.9812518353882154
Rule of 40 score: -12.251717264187025
Financial ratios for MULT.DE — quarterly report dated 2024-12-31
Total revenue: 105871111.1111111
Gross profit: 80884444.44444445
Operating income: 57648888.88888889
Net income: 8364444.444444444
Capital expenditures: 165555.55555555556
Operating cash flow: 826666.6666666666
Depreciation & amortization: 3438888.888888889
Net tangible assets: 178707777.77777776
Owner earnings: 11637777.777777776
Return on net tangible assets (%): 6.512183141938732
Capex to operating income (%): 0.28717909182021434
Buffett classification: The Great
Stock price: 4.21875
P/E ratio: 2.699894363127657
Shares outstanding: 21412140
Book value: 215281111.11111104
P/B ratio: 0.4196023755116051
Market cap (USD): 90332465.625
Debt to equity: 0.4231573188544179
Current ratio: 1.299057818748729
Quick ratio: 1.299057818748729
Effective tax rate (%): 12.950971322849213
COGS to revenue (%): 23.601024306284373
SG&A to revenue (%): 2.8336341883212293
Free cash flow (dilution-adjusted): -2718888.888888889
Buyback yield (%): 0.42066824742447073
Retained earnings: 109128888.88888888
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.641769354991574
FCF margin (%): -2.568112169934092
Rule of 40 score: -2.568112169934092
Financial ratios for MULT.DE — quarterly report dated 2025-03-31
Total revenue: 70838636.36363636
Gross profit: 50906818.18181818
Operating income: 32729545.454545453
Net income: 8219318.181818182
Capital expenditures: 52272.72727272727
Operating cash flow: 80337500
Depreciation & amortization: 3611363.6363636362
Net tangible assets: 189696590.9090909
Owner earnings: 11778409.090909092
Return on net tangible assets (%): 6.209077893526146
Capex to operating income (%): 0.15971113117144645
Buffett classification: The Great
Stock price: 4.413043478260869
P/E ratio: 2.874104113393324
Shares outstanding: 21412140
Book value: 228007954.54545474
P/B ratio: 0.4144272289577994
Market cap (USD): 94492704.78260869
Debt to equity: 0.5317697249398192
Current ratio: 1.201063493962531
Quick ratio: 1.201063493962531
Effective tax rate (%): 12.834417932031814
Interest coverage ratio: 11.632471728594506
COGS to revenue (%): 28.136930924957493
SG&A to revenue (%): 20.562096955308164
Free cash flow (dilution-adjusted): 76746590.9090909
Buyback yield (%): 0.7732679680011654
Retained earnings: 118710227.27272727
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.438310615487157
FCF margin (%): 108.34001732490617
Revenue growth (%): -33.089739381981516
Rule of 40 score: 75.25027794292465
Financial ratios for MULT.DE — quarterly report dated 2025-06-30
Total revenue: 79023750
Gross profit: 55046250
Operating income: 35141250
Net income: 8653750
Capital expenditures: 202500
Operating cash flow: -44721250
Depreciation & amortization: 4130000
Net tangible assets: 202298750
Owner earnings: 12581250
Return on net tangible assets (%): 6.219143716903837
Capex to operating income (%): 0.5762458649023584
Buffett classification: The Great
Stock price: 7.835294117647059
P/E ratio: 6.647660451832732
Shares outstanding: 21412140
Book value: 244841250
P/B ratio: 0.6852211977689026
Market cap (USD): 167770414.58823532
Debt to equity: 0.5520822165382672
Current ratio: 1.2718439265710972
Quick ratio: 1.2718439265710972
Effective tax rate (%): 13.180336092299974
Interest coverage ratio: 8.626265725682725
COGS to revenue (%): 30.342143975703507
SG&A to revenue (%): 19.96235309005204
Free cash flow (dilution-adjusted): -48871250
Buyback yield (%): 0.2019128347697094
Retained earnings: 126381250
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.666708719555921
FCF margin (%): -61.84374950568659
Revenue growth (%): 11.55458949597357
Rule of 40 score: -50.289160009713015